Patent Assignment
Reel/Frame 054123/0245
50% Assignment
Recorded: 2020-10-19
Pages: 3
Assignor
LICENTIA, LTD.
Executed: 2004-01-19
Assignee
LUDWIG INSTITUTE FOR CANCER RESEARCH
605 THIRD AVENUE, NEW YORK, NEW YORK, 10158
Covered Property
(1)
Therapy Targeting FLT4 (Veger-3) Expressed in Blood Vessels
Related Assignments
(9)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 14, 2007
From: LUDWIG INSTITUTE FOR CANCER RESEARCH; LICENTIA LTD.
To: VEGENICS LIMITED
Reel/Frame 020243/0259 →
Change of Name
Jul 6, 2011
From: VEGENICS LIMITED
To: VEGENICS PTY LIMITED
Reel/Frame 026552/0077 →
Assignment of Assignor's Interest
Oct 19, 2020
From: ALITALO, KARI; APRELIKOVA, OLGA; PAJUSOLA, KATRI; ARMSTRONG, ELINA
To: LICENTIA, LTD.
Reel/Frame 054100/0044 →
Assignment of Assignor's Interest
Oct 19, 2020
From: MAKINEN, TAIJA
To: LICENTIA, LTD.
Reel/Frame 054100/0066 →
Security Interest
Aug 23, 2022
From: OPTHEA LIMITED; VEGENICS PTY LTD
To: OCELOT SPV LP
Reel/Frame 060865/0465 →
Corrective Assignment to Correct the Supporting Documents Accompanying Security Interest - Appendix a Previously Recorded on Reel 060865 Frame 0465. Assignor(S) Hereby Confirms the Security Interest.
Aug 30, 2022
From: OPTHEA LIMITED; VEGENICS PTY LTD
To: OCELOT SPV LP
Reel/Frame 061356/0872 →
Security Interest
Jan 5, 2024
From: OPTHEA LIMITED
To: OCELOT SPV LP
Reel/Frame 066037/0845 →
Release of Security Interest Reel/Frame 066037/0845
Oct 13, 2025
From: OCELOT SPV LP
To: OPTHEA LIMITED
Reel/Frame 073081/0929 →
Release of Security Interest Reel/Frame 061356/0872
Oct 13, 2025
From: OCELOT SPV LP
To: OPTHEA LIMITED; VEGENICS PTY LTD
Reel/Frame 073084/0028 →